FDA Investigator: De Souza, Lance M
- De Souza, Lance M first started conducting FDA inspections in 2002, with the last inspection in 2018. Over that time, De Souza, Lance M has conducted 140 inspections at 107 companies across 113 sites.
Get De Souza, Lance M's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 McKesson Headquarters, San Francisco | July 2018
Available Now - $199
De Souza, Lance M
Human Drug Form 483
FDA 483 Hamamatsu / Queens PET Imaging Center | May 2015
Available Now - $199
De Souza, Lance M
Human Drug Form 483
FDA 483 AnazaoHealth, Las Vegas | January 2015
Available Now - $199
De Souza, Lance M
Human Drug Form 483
FDA 483 Biocompatibles UK, Ltd., Farnham | 2015
Out-of-stock
De Souza, Lance M
Human Drug Form 483
FDA 483 Schering Plough Sante Animale, Segre | 2015
Out-of-stock
De Souza, Lance M
Animal Drugs & Feed Form 483
FDA 483 Allergan Inc, Campbell | 2015
Out-of-stock
De Souza, Lance M
Human Drug Form 483
FDA 483 Haupt Pharma Latina Srl, Borgo San Michele (Latina) | 2014
Out-of-stock
De Souza, Lance M
Human Drug Form 483
FDA 483 Haupt Pharma Latina Srl, Latina | 2014
Out-of-stock
De Souza, Lance M
Human Drug Form 483
FDA 483 Impax Laboratories, Inc., Hayward | 2014
Out-of-stock
De Souza, Lance M
Human Drug Form 483
FDA 483 Excelvision AG, Hettlingen | 2014
Out-of-stock
De Souza, Lance M
Human Drug Form 483
FDA 483 Haupt Pharma Wolfratshausen GmbH, Wolfratshausen | 2014
Out-of-stock
De Souza, Lance M
Animal Drugs & Feed Form 483
FDA 483 Haupt Pharma Wolfratshausen GmbH, Wolfratshausen | 2014
Out-of-stock
De Souza, Lance M
Animal Drugs & Feed Form 483
FDA 483 Biomarin, San Rafael | 2014
Out-of-stock
De Souza, Lance M
Human Drug Form 483
FDA 483 Molecular Imaging Program at Stanford, Palo Alto | 2014
Out-of-stock
De Souza, Lance M
Human Drug Form 483
FDA 483 UCSF Radiopharmaceutical Facility, San Francisco | 2013
Out-of-stock
De Souza, Lance M
Human Drug Form 483
FDA 483 The Queen's Medical Center, Honolulu | 2013
Out-of-stock
De Souza, Lance M
Human Drug Form 483
FDA 483 Questcor Pharmaceuticals, Inc., Hayward | 2013
Out-of-stock
De Souza, Lance M
Human Drug Form 483
Co-Investigators (49)
- Jolanna A. Norton, FDA Investigator
- Lance M. De Souza, FDA Investigator
- Aaron Weisbuch, FDA Investigator
- Samina S. Khan, FDA Investigator
- David Eng, FDA Investigator
- Eileen A. Liu, FDA Investigator
- Lucila B. Nwatu, FDA Investigator
- Stephanie A. Slater, FDA Investigator
- Eric L. Dong, FDA Investigator
- Ashar P. Parikh, FDA Investigator
- Anh Lac, FDA Investigator
- Jennifer H. Rhyu, FDA Investigator
- Henry K. Lau, FDA Investigator
- Robert D. Tollefsen, FDA Investigator
- Uttaniti Limchumroon, FDA Investigator
- Daniel J. Roberts, FDA Investigator
- Rebecca Rodriguez, FDA Investigator
- Jennifer L. Johnson, FDA Investigator
- Patricia F. Hughes Troost, FDA Investigator
- Lakshmi Ran Narasimhan, FDA Investigator
- Hughes Troost, Patricia F, FDA Investigator
- Mark E. Chan, FDA Investigator
- Maida Henesian, FDA Investigator
- Sangeeta M. Khurana, FDA Investigator
- Sandra S. Saniga, FDA Investigator
- Bo Chi, FDA Investigator
- William V. Millar, FDA Investigator
- Marie K. Kinkade, FDA Investigator
- Peter E. Baker, FDA Investigator
- Sam Pepe, FDA Investigator
- Hala L. Selby, FDA Investigator
- Carl Lee, FDA Investigator
- Sharon K. Thoma, FDA Investigator
- Rochelle B. Young, FDA Investigator
- Jeffrey M. Watson, FDA Investigator
- Kevin P. Foley, FDA Investigator
- Darlene B. Almogela, FDA Investigator
- Gerald N. McGirl, FDA Investigator
- Erica L. Nicoll, FDA Investigator
- Shelley H. Beausoleil, FDA Investigator
- Timothy C. Grome, FDA Investigator
- Jeffrey W. Shrifter, FDA Investigator
- Prabhu P. Raju, FDA Investigator
- Joseph P. Iser, FDA Investigator
- Jolene S. Hedgecock, FDA Investigator
- David A. Lum, FDA Investigator
- Daniel C. Geffin, FDA Investigator
- Edward R. Schiffman, FDA Investigator
- William J. Weis, FDA Investigator